Adopting Automation - Where Do I Even Start?

Adopting Automation - Where Do I Even Start?

Thursday, April 14, 2022 1:30 PM to 2:15 PM · 45 min. (America/Los_Angeles)
Breakout Room 3 - Second Floor
Breakout Session

Information

With the benefits of automation - more efficient, reliable, and reproducible operations - being well known, more and more biotech companies are faced with how they should adopt automation. Learn about the different approaches companies can take (build, buy, or a blend of both) and what path might make automation the most accessible for you and your team.

Artificial IncArtificial is redefining lab automation to accelerate the pace of life science discoveries.  Artificial offers a single software platform that embraces the fundamental role of people in the scientific process, so any lab and anyone can leverage the power of automation. With the Artificial Product Suite, labs can leverage a suite of unified applications on a single, intuitive interface to orchestrate manual and automated workflows, augment manual tasks, and streamline their operations.  The Artificial Suite includes: LabOps - an application for running, monitoring, and orchestrating manual and automated protocols in a single workflow Assistants - a digital assistant that provides step-by-step guidance for all of the manual steps in a workflow Labs - an application for building a lab's Digital Twin that is encoded with each asset's meta-data Workflows - a configurator that connects all of the people, hardware, software, and data to create a seamless workflow 

Registered attendees

Aaron Schaller
Aaron Schaller
CTO & Co-FounderMeliBio
Abraham Grosman
Abraham Grosman
Co-Founder/Researcher SynCan
AY
Adil Yusuf
CTOMedium Biosciences

Log in